These reports collectively show that PEAC frequently carries KRAS mutations and may harbor occasional APC or TP53 alterations, partially overlapping with the classical colorectal adenocarcinoma mutation spectrum. This evidence concerns the gene KRAS and colorectal adenocarcinoma.